U.S. Markets open in 10 hrs, 42 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,387.61 | 936.42 | 11.08% |
| NASDAQ | 1,844.25 | 194.74 | 11.81% |
| S&P 500 | 1,003.35 | 104.13 | 11.58% |
| Day Low 09:32 AM EDT | 19.21 | |
|---|---|---|
| Day High 09:51 AM EDT | 22.00 |
|
| Range | 2.79 | |
| Volume | 728,538 | |
| 30-Day Avg. Vol. | 751,000 |
|
| Difference | -2.99% | |
| Market Cap. | 600.7 M | |
| Change | 51.6 M | |
| Shares Out. | 30 M | |
| Percent Traded | 2.43% | |
| Revenue (LFY) | 0 | |
| Earnings (TTM) | -31.74 M | |
| Next Earnings | 09/24/2008 |
|
| EPS (TTM) | -1.86 |
| 52-Wk Low 7/3/08 | 11.53 | |
|---|---|---|
| 52-Wk High 9/8/08 | 34.40 |
|
| Range | 22.87 | |
| Prev. Close 10/10/08 | 18.30 | |
| Today's Open | 19.97 | |
| Change | 9.13% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.8881 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -14.00 |
Medivation motivates medicine makers. The company acquires, develops, and sells (or partners with companies working on) early-development stage biopharmaceuticals. Medivation initiates drug development ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.384 3/31/08 | -0.54 3/31/08 |
-0.156
Missed
|
| Last Quarter | -0.539 6/30/08 | -0.64 6/30/08 |
-0.101
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -46,000.00 | -74,323.00 |
| Operating Income | -18.72 M | -33.76 M |
| Net Income | -18.54 M | -31.74 M |
